George Tomlinson is a member of the community providing the groundbreaking perspectives and inspiring contributions that define IHPME.
Professional Interests: Clinical effectiveness, health research methods (biostatistics, randomized controlled trials, Bayesian analysis, meta-analysis).

RECLAIM is an adaptive platform randomized trial comparing the effectiveness of various treatments for lingering symptoms of COVID-19.
Translating Human Physiological Processes to Predict Clinical Outcomes via Computer Simulation
Published: 2005